chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Blood urea increased, Convulsion, Diarrhoea, Hyperchloraemia, Hypernatraemia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Hypoglycaemia, Platelet count increased, Pyrexia, Strabismus, White blood cell count increased
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 43.0
Sex: M
Vaccine: LYME
Symptoms: Injection site pain, Myalgia
Clinical narrative: Report 2001025054-1 describes aching of the arm in a 43 year old male who received Lyme disease vaccine recombinant OspA (LYMErix). This report was received from the vaccinee's spouse and has not been confirmed by a physician or other healthcare professional. Medical history, concurrent conditions, and concurrent medications were not specified. The vaccinee received his first and second injections of LYMErix in Oct. 1999 and Nov. 1999, respectively. Exact dates of immunization were not known. He received his third injection of LYMErix in Aug. 2000, 10 months after the first injection. The recommended interval between the first and third injections is 12 months. Approx. one or two months following receipt of the third injection of LYMErix, he reportedly began to experience aching of the arm into which the vaccine had been administered. The aching occurred "off and on." He did not seek medical attention for this. The vaccinee reportedly believed the aching was possibly related to LYMErix administration. As of 02 October 2001, the aching persisted "off and on." Additional information was received from the vaccine provider on 03 December 2001. The vaccine provider considered the aching in the arm to represent myalgias. he stated that the vaccinee did not report any adverse event to him, and did not seek medical attention for the myalgias.
Age: 0.4
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Respiratory arrest
Clinical narrative: Mother found child in crib not breathing. Called an ambulance, but unable to resuscitate. COD as per death certificate -- cystic encephalomalacia
Age: 0.4
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Apnoea, Encephalopathy
Clinical narrative: Mother found child in crib not breathing. Called an ambulance, but unable to resuscitate. COD as per death certificate -- cystic encephalomalacia
Sex: F
Vaccine: PPV
Symptoms: Injection site oedema, Injection site pain, Pain, Swelling
Clinical narrative: Information has been received from a pharmacist concerning a female pt who was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (lot 640577/0995L). Subsequently, a few hours post vax, the pt experienced pain and swelling and went to the ER. In the ER, she was treated with diphenhydramine hydrochloride (Benadryl) and was observed for 3 hours prior to being released. It was reported that another pt (WAES0201USA00517) had a similar experience following exposure to pneumococcal vaccine 23 polyvalent. The reporter expressed a concern regarding the lot. Follow-up information from a registered nurse indicated that the patient experienced swelling and pain at the injection site within 3 hours of her vaccination. The patient's pain and swelling became so bad that she went to the emergency room. She was treated with Benadryl PO, observed for three hours and then released. It was reported that the patient took Benadryl for a few days after her emergency room visit and subsequently recovered. Upon internal review, the pt's events were considered to be "Other Important Medical Events". Additional information has been requested.
Age: 45.0
Sex: F
Vaccine: FLUX
Symptoms: Cough, Multiple sclerosis, Muscular weakness, Myelitis transverse, Paraplegia
Clinical narrative: 3 days post vax, the pt developed progressive bilateral leg weakness, fever and cough. 5 days post vax, she developed paraplegia and sensory impairment to the T6-T7 level (pin prick, light touch, temperature). The pt was treated with IV steroids and discharged to a long-term care facility without any improvement on 12/11/01. Pt with PHH sign for MS and an episode of acute transverse myelitis and paraplegia.
Age: 45.0
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia, Sensory disturbance
Clinical narrative: 3 days post vax, the pt developed progressive bilateral leg weakness, fever and cough. 5 days post vax, she developed paraplegia and sensory impairment to the T6-T7 level (pin prick, light touch, temperature). The pt was treated with IV steroids and discharged to a long-term care facility without any improvement on 12/11/01. Pt with PHH sign for MS and an episode of acute transverse myelitis and paraplegia.
Age: 0.3
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Agitation, Cough, Pneumonia, Upper respiratory tract infection, Viral infection
Clinical narrative: Within 24 hours, post vax, pt was inconsolable with cough, congestion and RSV. Two days, post vax, after pt's 1st shots; pneumonia.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Migraine, Myalgia
Clinical narrative: The pt developed cluster migraine headaches, aches and pains in his joints and muscles. *Follow-up report 2/19/03: From PT's parents: "There is no change he is still disable. He is my son and lives at home with us."
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Incoherent, Loss of consciousness
Clinical narrative: Employee fainted and was incoherent approx. one hour after flu shot injection was given. On 12/12/2001- ER visit and on 12/13/2001-follow up Dr. office visit
Age: 0.3
Sex: M
Vaccine: DTAP, HEP, IPV, PNC
Symptoms: Crying, Pyrexia, Rash
Clinical narrative: Pt's mother stated that she took the child to the ER on 01/16/2002 at around 5:30pm with a temp of 106 deg. F. The pt had rash and was excessively crying. The pt was treated with Benadryl injection and Benadryl prescription. Followed up with the doctor today and was given 2 more prescriptions and was told the pt has a viral infection, also.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Swelling
Clinical narrative: The pt developed swelling and erythema 11-12cm below vaccine site 3-4 hours after injection. Ice was applied and then the swelling was down slightly.
Age: 0.25
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Pyrexia, Rash, Urticaria
Clinical narrative: The pt developed rash, fever, hives within 24hrs following the vaccination with DTap, HIB, IPV and Prevnar. Rash/hives are on theback and belly of the pt.
Age: 60.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site rash, Pain
Clinical narrative: The pt developed left hip pain 24 hours later and 11x6cm rash at injection site.
Age: 47.0
Sex: F
Vaccine: FLU3, HEPA, IPV, JEV, PPV
Symptoms: Chills, Injection site induration, Nausea, Pneumonia, Tremor
Clinical narrative: Approx. 48 hrs after vaccine, pt reports shaking chils with nausea and induration at injection site that developed that night of the vaccine. Symptoms lasted a week then resolved completely. Pt also  had pneumonia in April.
Age: 31.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Chest discomfort, Dyspnoea, Pain, Swelling, Urticaria
Clinical narrative: Within 1 1/2 hours the pt broke out in hives localized to both arms and experienced tightness in chest with some difficulty in breathing. Called provider at clinic, told to take Benedryl. Pt took 2 tps. fell asleep and woke up 2 hrs. later. Hives were gone, and breathing was  okay. Next day, she feels swollen and achy.
Age: 42.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Coordination abnormal, Joint stiffness, Muscular weakness
Clinical narrative: The pt developed knee pain and stiffness in 12/06/2001. On 12/08/01 he developed some weakness in hand and had difficulty in coordination.
Age: 2.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Injection site erythema
Clinical narrative: Vaccine was administered on 01/07/2002. On 01/21/2002, pt developed quarter sized rednes around the site of Varivax which was administered on the left thigh.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Pt received MMR vaccine on 01/02/2002 after being counseled about not becoming pregnant for 3 months after vaccine. Pt denied pregnancy at that time. In for pregnancy test on 01/08/2002 with positive results. The last menstrual period was at 12/04/2001.
Age: 5.0
Sex: M
Vaccine: HEPA
Symptoms: Diarrhoea, Nausea, Rash
Clinical narrative: HepA-ped dose #1 given on 09/25/2001/recall bad lot # pt notified RTC/HepA-ped dose repeat given on 01/22/2002. Pt's mom called on 01/24/2002 stating that the pt had rash on both hands, diarrhea, and nausea. On 01/24/2002 mom also stated the same reaction with first shot which she forgot to report. It only lasted for a day and disappeared.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Feeling hot, Pruritus, Swelling
Clinical narrative: Left upper thigh has redness, swelling, itching and warm to touch.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Urticaria
Clinical narrative: The pt developed urticarial rash for 1 day post immuning. Benedryl was prescribed.
Age: 13.0
Sex: M
Vaccine: HEP
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: The pt developed a generalized headache(severe), nausea and dizziness.
Age: 1.0
Sex: M
Vaccine: HBHEPB, MMR, VARCEL
Symptoms: Erythema, Injection site induration, Pain, Pyrexia
Clinical narrative: Left thigh with pain/fever/redness. 5.5cm by 3.75 cm induration with erythema. within 24 hours, IM Comvax and Varicella. Follow-up 2 days later, no erythema 1 inch induration.
Age: 13.0
Sex: M
Vaccine: HEP, HEPA
Symptoms: Cold sweat, Depressed level of consciousness, Hyperhidrosis, Syncope vasovagal
Clinical narrative: Patient had low level of consciousness, became diaphoretic and clammy. Ammonia inhalent used. Pt assisted to exam table after alert. Vital signs taken. Dr. also checked pt.  DX Vasovagal reaction.
Age: 0.4
Sex: M
Vaccine: DTAP, HBPV, IPV
Symptoms: Diarrhoea, Malaise, Pyrexia, Rash papular
Clinical narrative: Fever, malaise,  diarrhea within 12 hours after Prevnar. Also some scatted papules lower abdomen
Age: 12.0
Sex: F
Vaccine: HEP
Symptoms: Hypoaesthesia, Lethargy, Mouth ulceration, Paraesthesia, Rash
Clinical narrative: 8/15/01 evening--tingling in hand/limbs, numbness. Sores in mouth, lips sore, rash and lethargic for 5 days. rash all over body and in mouth. Called ECHD--given CDC #. 4-5 days later, felt better. Lost 6 pounds.
Age: 3.0
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR
Symptoms: Pruritus, Pyrexia, Rash
Clinical narrative: Rash, (itchy), fever. Dx. Zyrtec, Caladryl
Age: 1.08
Sex: M
Vaccine: HEP, MMR, VARCEL
Symptoms: Convulsion, Pyrexia
Clinical narrative: Low grade fever and loose stools on day of immunization prior to immunizations. Within 6 hrs of receiving immunizations, pt developed fever of 103-104 degrees F. and had generalized tonic/clonic seizure lasting 90 sec. On 01/12/2002 again, the pt had fever and generalized seizure. No history of seizures before 01/04/2002
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Hypokinesia, Injection site pain
Clinical narrative: Mom reported to the school nurse on 12/6/01, that the pt was complaining that "his leg (R) hurt and he couldn't move it easy". Mom reported later to the physician that "when he awoke, he really couldn't move his (R) leg". He no more symptoms after 48 hours.
Age: 1.25
Sex: M
Vaccine: HIBV, IPV, MMR
Symptoms: Arthralgia, Crying, Irritability, Personality change, Pyrexia
Clinical narrative: Parent's relate that from the day he received MMR, HIB and IPV, he had change in behavior. He was clingy, insecure and screaming at night. This behavior progressed and fever of 102F-104F started 9 days, post vax, and continued for 4 full days with marked irritability. He complained of "boo-boos" in his knees and wrists.
Age: 54.0
Sex: F
Vaccine: TD
Symptoms: Injection site erythema, Injection site swelling, Pruritus
Clinical narrative: Within 24 hours of administration, the pt described severe redness, swelling and itching involving nearly her whole arm.
Age: 1.3
Sex: F
Vaccine: DTAPH, IPV, MMR
Symptoms: Rash
Clinical narrative: The pt developed a flat, red rash concentrated on her trunk. Pt still has rash.
Age: 0.6
Sex: M
Vaccine: HEP, IPV
Symptoms: Dermatitis contact
Clinical narrative: On 1/8/02, the pt broke out in a rash similar in appearance to a contact dermatitis (per PMD), non-pruritic. The pt is breast fed.
Sex: M
Vaccine: FLU3
Symptoms: Nasal congestion, Pyrexia
Clinical narrative: Post vax, the pt developed chills, congestion and fever.
Age: 72.0
Sex: F
Vaccine: FLUX
Symptoms: Ear disorder, Eye disorder, Headache, Infection, Pharyngitis
Clinical narrative: Became sick after the flu shot, 2 years in a row. Post vax, the pt developed sinus infection, ear infection, throat infection, eye infection and headaches. Not all at the same time but continuing for about 3 months. Did no get a flu shot in 2001. Did not get sick again. The doctors did not believe the flu shots caused it.
Age: 72.0
Sex: F
Vaccine: FLUX
Symptoms: Sinusitis, Vaccine positive rechallenge
Clinical narrative: Became sick after the flu shot, 2 years in a row. Post vax, the pt developed sinus infection, ear infection, throat infection, eye infection and headaches. Not all at the same time but continuing for about 3 months. Did no get a flu shot in 2001. Did not get sick again. The doctors did not believe the flu shots caused it.
Sex: F
Vaccine: PNC
Symptoms: Injection site inflammation
Clinical narrative: The pt experienced an inflammatory reaction following Prevnar vaccination.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: The pt experienced Type III hypersensitivity reaction, as well as, arm soreness, redness and swelling after vaccination with Pneumovax.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Hives
Age: 0.3
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Pyrexia, Screaming
Clinical narrative: Pt in for 4 month check-up and routine immunizations were given. When mom brought pt in on 1/15/02, she stated that the pt had ran a fever of 102.5F and had screamed for 3 days.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Hives after Rocephin given on 12/26/01 for strep and at 19 months of age on 8/15/01, had hives from MMR given at well check appt.
Age: 7.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Abdominal pain upper, Erythema, Urticaria
Clinical narrative: Information has been received from a health professional concerning her 7 year old daughter who on 1/9/02 was vaccinated with a 1st dose of pneumococcal vaccine 23 polyvalent (lot 636158/1456K). It was noted that the pt received the vaccine at the recommendation of the allergist. There was no concomitant medication. Within 1 minute of vaccination, the pt began to have difficulty breathing, her face and ears turned red and she broke out with small hives on her cheeks. There were about 30 hives on each cheek. The child reported that her face felt like it was tightening. The child was given diphenhydramine hydrochloride (Benadryl) in the office and the symptoms subsided relatively quickly. The pt has recovered. It was reported that the pt had similar experience after vaccination with MMRII (WAES0201USA01785). Upon internal review, difficulty breathing was considered to be an "Other Important Medical Event". No further information is available.
Age: 7.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Dyspepsia, Dyspnoea, Erythema, Urticaria
Clinical narrative: Information has been received from a health professional concerning her 7 year old daughter who on 1/9/02 was vaccinated with a 1st dose of pneumococcal vaccine 23 polyvalent (lot 636158/1456K). It was noted that the pt received the vaccine at the recommendation of the allergist. There was no concomitant medication. Within 1 minute of vaccination, the pt began to have difficulty breathing, her face and ears turned red and she broke out with small hives on her cheeks. There were about 30 hives on each cheek. The child reported that her face felt like it was tightening. The child was given diphenhydramine hydrochloride (Benadryl) in the office and the symptoms subsided relatively quickly. The pt has recovered. It was reported that the pt had similar experience after vaccination with MMRII (WAES0201USA01785). Upon internal review, difficulty breathing was considered to be an "Other Important Medical Event". No further information is available.
Age: 20.0
Sex: F
Vaccine: HEP
Symptoms: Injection site induration, Injection site inflammation, Injection site pain, Muscle atrophy, Muscular weakness
Clinical narrative: Information has been received from a 20 year old female RN who was vaccinated with the 1st dose of Hep-B vaccine recombinant (yeast). Subsequently, the pt experienced soreness at the injection site and fever. Subsequently, the pt recovered from the soreness at the injection site and fever. On 8/17/01, the pt was vaccinated with the 2nd dose of Hep-B vaccine recombinant (yeast). On approx. 8/22/01, approx. 5 to 10 days, post vax, the pt noted that her arm had started to disintegrate and that her muscle was deteriorating. She reported that it looked like the flesh on her arm was burnt. She was not hospitalized but has lost considerable strength in her arm. She cannot lift or pull as much as she had been able to previously. The area continues to become larger with no resolution. The pt reported that she was on exercises to try to strengthen her arm. She also reported that she previously took allergy shots with no reactions but she had not taken them for over 1 year. Soreness at injection site, fever muscular atrophy, muscular weakness and skin or skin appendage condition were considered to be disabling. Additional information has been requested. Additional info has been received from a physician. The physician reported that the pt developed some inflammation and induration beginning on approximately 8/22/01 (five to ten days) after receiving her second dose of hep b vaccine recombinant. The inflammation and induration disappeared and had been replaced by muscle atrophy. The muscles sunken in an area by about 1cm by 2 1/2cm in the posterior deltoid area. On 1/12/02 the pt's hep B surface anti-body titer was 24. The physician reported that the pt had received some physical therapy but no other medication at this time. The pt was still experiencing muscle weakness. Additional information has been received from the physician. The physician reported that he believed that the patient needed physical theapy. Additional information has been received from the physician. The physician reported that the patient received her second dose of hepatitis B vaccine recombinant (yeast) on 08/17/01 and subsequently developed inflammation in the area which became erythematous, indurated and tender. He reported that she had no sterile abscess or other acute problem. However, subsequently after the inflammation had resolved the patient developed significant atrophy in the posterior left deltoid. The physician reported that she did have some physical therapy which he did seem to help her and therefore that was stopped. She has persisted in having atrophy in the area and weakness in the half centimeters or more. There is weakness in the area secondary to the loss of muscle tissue. The physician reported that the patient's titer was good and that he thought that the patient would need ongoing physical therapy. The physician also reported that the patient's liver panel on 01/21/02 was "normal". No additional information is expected.
Age: 20.0
Sex: F
Vaccine: HEP
Symptoms: Pyrexia
Clinical narrative: Information has been received from a 20 year old female RN who was vaccinated with the 1st dose of Hep-B vaccine recombinant (yeast). Subsequently, the pt experienced soreness at the injection site and fever. Subsequently, the pt recovered from the soreness at the injection site and fever. On 8/17/01, the pt was vaccinated with the 2nd dose of Hep-B vaccine recombinant (yeast). On approx. 8/22/01, approx. 5 to 10 days, post vax, the pt noted that her arm had started to disintegrate and that her muscle was deteriorating. She reported that it looked like the flesh on her arm was burnt. She was not hospitalized but has lost considerable strength in her arm. She cannot lift or pull as much as she had been able to previously. The area continues to become larger with no resolution. The pt reported that she was on exercises to try to strengthen her arm. She also reported that she previously took allergy shots with no reactions but she had not taken them for over 1 year. Soreness at injection site, fever muscular atrophy, muscular weakness and skin or skin appendage condition were considered to be disabling. Additional information has been requested. Additional info has been received from a physician. The physician reported that the pt developed some inflammation and induration beginning on approximately 8/22/01 (five to ten days) after receiving her second dose of hep b vaccine recombinant. The inflammation and induration disappeared and had been replaced by muscle atrophy. The muscles sunken in an area by about 1cm by 2 1/2cm in the posterior deltoid area. On 1/12/02 the pt's hep B surface anti-body titer was 24. The physician reported that the pt had received some physical therapy but no other medication at this time. The pt was still experiencing muscle weakness. Additional information has been received from the physician. The physician reported that he believed that the patient needed physical theapy. Additional information has been received from the physician. The physician reported that the patient received her second dose of hepatitis B vaccine recombinant (yeast) on 08/17/01 and subsequently developed inflammation in the area which became erythematous, indurated and tender. He reported that she had no sterile abscess or other acute problem. However, subsequently after the inflammation had resolved the patient developed significant atrophy in the posterior left deltoid. The physician reported that she did have some physical therapy which he did seem to help her and therefore that was stopped. She has persisted in having atrophy in the area and weakness in the half centimeters or more. There is weakness in the area secondary to the loss of muscle tissue. The physician reported that the patient's titer was good and that he thought that the patient would need ongoing physical therapy. The physician also reported that the patient's liver panel on 01/21/02 was "normal". No additional information is expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Coordination abnormal, Eye disorder, Eyelid ptosis, Gait disturbance
Clinical narrative: Information has been received from a physician concerning a 1 year old male who on approximately 04/18/2001 was vaccinated with a dose of varicella virus vaccine live. On 05/06/2001, 18 days later, the pt was admitted to the hospital with cerebellar ataxia. It was reported that his symptoms were wide gait, ptosis and eye deviations. His MRI was normal and a CSF had no RBC's, 1 WBC, was negative for enterovirus, and a "viral culture ws negative." It was noted that the patient was not treated with acyclovir. It was reported that there was a family history on the pt's maternal side of an uncle that died from VZV encephalitis (no vaccine) and an ant with recurring herpes simplex (no vaccine). Subsequently, the pt fully recovered. The pt's sister subsequently experienced herpes zoster after receiving varicella virus vaccine live (MSD, WAES 0201USA01628).
Age: 23.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Abortion spontaneous, Back pain, Chromosome abnormality
Clinical narrative: Information has been received from a husband and his 23 year old wife who on 6/27/01, the wife was vaccinated with varicella virus vaccine live and MMR. The pt stated that after she had the vaccinations, she found out that she had become pregnant on 6/17/01. Subsequently, on 9/10/01, the pt had a "natural miscarriage". Her physician told her that the miscarriage was not because of the vaccines, but because of "some chromosome problem". The pt further stated that after the miscarriage, her health was good although she was "still suffering from back pain but reducing day by day". Back pain was considered to be an incidental finding. Additional information is not expected.
Sex: F
Vaccine: VARCEL
Symptoms: Abortion spontaneous, Laboratory test abnormal
Clinical narrative: Information has been received from a physician concerning a mother of a pediatric pt who on 4/13/01 was vaccinated with varicella virus vaccine live. The physician reported that the female reported that she performed a home pregnancy test that was negative. A week later, she had a lab test that confirmed pregnancy. The physician reported that because the woman was not the doctor's pt, there was no additional information related to last menstrual period (LMP) or date of delivery. The physician "feels the woman is about 6 weeks pregnant". The physician did not have the name of the obstetrician/gynecologist. In follow-up, the physician reported that she was informed that the pt had an early miscarriage of this pregnancy. Additional information has been requested.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Anuria, Asthenia, Constipation, Hypoaesthesia, Myelitis transverse
Clinical narrative: The pt developed a transverse myelitis, weakness, numbness of both legs, inability to urinate and difficulty with morning bowels. She has improved.  Patient is walking without a walker, feels like his strenght is not yet fully back to normal.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Cyanosis, Hypotonia, Screaming, Stupor
Clinical narrative: Post vax, the pt cried substantially and became hypotonic/hyporesponsive/dusky in color which lasted 1-5 minutes. He was brought to the hospital by EMS. Symptoms resolved spontaneously.
Age: 0.6
Sex: F
Vaccine: DTPHIB, HEP, OPV
Symptoms: Autism, Convulsion, Cyanosis, Dyskinesia, Pallor
Clinical narrative: Seizure, ADD, Autism, face turn blue-white and bubbles out from mouth and jerking.
Age: 0.6
Sex: F
Vaccine: DTPHIB, HEP, OPV
Symptoms: Psychomotor hyperactivity, Salivary hypersecretion
Clinical narrative: Seizure, ADD, Autism, face turn blue-white and bubbles out from mouth and jerking.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Rash, Rash macular
Clinical narrative: Pt developed 1cm erythematous macular exanthem, non pruritic at injection site L arm. No fever,No previous reaction to flu vaccine. No flu or cold symptoms 2 wks prior to receiving vaccine. No allergies to eggs.
Age: 17.0
Sex: F
Vaccine: FLU3
Symptoms: Rash macular, Rash pruritic
Clinical narrative: Pt reports within 24 hr's after receiving vaccine they developed 5cm diameter circular, pruritic macular exanthem at injection site. No fever, no previous reaction to flu vaccines, no cold or fever symptoms 2 wks prior to receiving vaccine, No allergy to eggs. Pt was given 10 days antibiotic (Keflex) for cellulitis.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Pt reported that on the same night she rec'd the flu vaccine (11/29/01). She developed welts to her face with itching. This persisted Thursday evening 11/29/01 and Friday 11/30/01. She considered taking Benadryl, but didn't as symptoms didn't progress, she continues to have spots on her face as of 12/4/01, but no pruritis. She also had itching to her scalp, neck and arms but did not observe any welts.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site reaction, Injection site warmth, Pruritus, Urticaria
Clinical narrative: Pt rec'd flu vaccine 11/16/01. On 11/17/01 R arm at injection site developed hives, welt, itchy, redness, site warm to touch. On 11/19/01 R deltoid site size of small lemon, warm to touch and still itchy. Pt put ice on the area on 11/17 and warm compress 11/18/01. On 11/26/01 inflammation subsiding.
Age: 0.3
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, DTAP, HIBV, IPV, PNC
Symptoms: Pyrexia, Urticaria
Clinical narrative: Pt received vaccines @ 9am 1/3/02, onset of urticaria, fever 101-103F 6pm through 1/4/02. Symptoms resolved 1/5/02am. 2nd episode diffuse hives day of vaccines.
Age: 62.0
Sex: F
Vaccine: FLU3, TD
Symptoms: Back pain, Blister, Injection site erythema, Injection site vesicles, Pain
Clinical narrative: 40 days after vaccination, pt called to report redden blister area on L upper outer arm. Approximately 4 1/2" (shoulder), outer arm area, 2 large blisters developed & has continued to have area of tiny blisters, redness and pain to L arm from her shoulder to finger tips, pain from shoulder to back. Several areas of blisters, redness down arm continue.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, PNC
Symptoms: Cellulitis, Injection site pain, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Immunizations given on 1/15/02. Pt presented in office on 1/16/02 with swelling 1st noticed @4pm on 1/16/02. Pt was treated with antibiotics for the possibility of cellulitis and was seen again on 1/17/02, arm was still hot and painful but had full function of arm. 1st 2 immunizations were DT ?? possible seizures but had subsequently rec'd DTaP for # 3 & 4.
Age: 1.3
Sex: M
Vaccine: HBHEPB, IPV, MMR, PNC
Symptoms: Pyrexia
Clinical narrative: Reported temperature of 13F lasting 24 hrs.
Age: 0.2
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Rash
Clinical narrative: Immunization on 1/15, pt developed rash on 1/16/02.
Age: 0.5
Sex: M
Vaccine: DTAP, FLU3, PNC
Symptoms: Erythema multiforme
Clinical narrative: Pt rec'd DTaP, Prevnar, Flu vaccine and Synagis. developed erythema multiforme 1/13/02. On 1/15/02 pt presented to office. Tx Atarax improved.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain upper, Blood pressure decreased, Erythema, Feeling abnormal, Heart rate increased
Clinical narrative: Approx. 20 minutes, post vax, the pt stated that she "didn't feel right". She complained of being "bright red" all over. She complained of nausea, epigastric pain and tingling in all extremities. No SOB. BP was 91/70; Pulse was 100. She was given Benadryl 25mg at 10:00. At 10:30, there was no improvement and EMS were called. The pt was transported to the hospital at 10:50. Her eyes were bloodshot. She was treated with Zantac, Benadryl and prednisone at the hospital.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Ocular hyperaemia, Paraesthesia
Clinical narrative: Approx. 20 minutes, post vax, the pt stated that she "didn't feel right". She complained of being "bright red" all over. She complained of nausea, epigastric pain and tingling in all extremities. No SOB. BP was 91/70; Pulse was 100. She was given Benadryl 25mg at 10:00. At 10:30, there was no improvement and EMS were called. The pt was transported to the hospital at 10:50. Her eyes were bloodshot. She was treated with Zantac, Benadryl and prednisone at the hospital.
Age: 1.08
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Fever and rash
Age: 73.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: The client states that she received Pneumovax vaccine on 12/04/01 at approx. 14:30. She states that the swelling began at approx. 18:00 on 12/04/01 and has gotten progressively worse. Her right upper arm is reddened, markedly swollen, warm and tender to touch. The client denies itching at this time but states it was itching last night. She has used Cortaid cream and ice packs with minimal relief.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Hypersensitivity, Oedema peripheral, Pruritus, Tongue oedema
Clinical narrative: Pt very poor historian. Had to wait for ER record to complete form. Tongue swelled, started itching and legs swelled. Went to ER at 14:10 on Sunday. Told ER doctor the same thing she told me; that eggs bothered her ulcer and sometimes made her nauseated. No hives or itching or anything. The doctor Rx'd as allergy with Zantac, Medrol Dose Pack and Benadryl 50mg tid. To follow-up with regular MD the next day.
Age: 21.0
Sex: F
Vaccine: FLU3, MEN
Symptoms: Paraesthesia
Clinical narrative: 30 minutes, post vax, the pt had tingling in arm. No pain or swelling. PE-nml.
Age: 1.4
Sex: M
Vaccine: DTAP, HIBV, IPV, MMR, PNC
Symptoms: Diarrhoea, Irritability, Oral intake reduced
Clinical narrative: The child was very irritable, decreased appetite and inconsolable crying for the evening after shots. Mother gave child Tylenol with codeine after regular Tylenol had not helped. Child did sleep through the night. His appetite diminished and had loose stools the next day. Still somewhat fussy.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Anaphylactic reaction, Dyspnoea
Clinical narrative: Employee received  vaccine on 10/22/2001. She went to the ER dept on 10/23/2001 with shortness of breath-dexcribed as anaphylactic reaction. Given IV pepcid, epinephrine and breathing treatment.
Age: 84.0
Sex: F
Vaccine: FLU3
Symptoms: Diarrhoea, Pyrexia, Vomiting
Clinical narrative: The pt complained of fever, diarrhea, and vomiting for 2-3 days after the second injection (first injection not verified).
Age: 0.5
Sex: F
Vaccine: DTAP, HBHEPB, PNC
Symptoms: Agitation, Crying, Decreased appetite, Irritability, Skin reaction
Clinical narrative: The pt showed in decrease of appetite, increased fussiness, crying, poor sleeping. Despite this she had gained weight. Exam normal. Local reaction on thigh.
Age: 0.5
Sex: F
Vaccine: DTAP, HBHEPB, PNC
Symptoms: Sleep disorder, Weight increased
Clinical narrative: The pt showed in decrease of appetite, increased fussiness, crying, poor sleeping. Despite this she had gained weight. Exam normal. Local reaction on thigh.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site hypersensitivity
Clinical narrative: 12-14 hours post flu vaccination, pt noted tenderness at injection site.